1.
Two-year outcomes of the MINIject drainage system for uncontrolled glaucoma from the STAR-I first-in-human trial.
Denis Philippe, Hirneiß Christoph, Durr Georges M, Reddy Kasu Prasad, Kamarthy Anita, Calvo Ernesto et al.
Br J OphthalmolOct 202043 citationsClinical Trial
The MINIject device effectively lowered IOP and reduced medication for uncontrolled glaucoma patients over two years, showing promise as a safe, sustained treatment option.